✦ LIBER ✦

Approaching the Asymptote: Obstacles and Opportunities for Nanomedicine in Cardiovascular Disease

✍ Scribed by Sascha N. Goonewardena

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MicroRNA therapeutics for cardiovascular

✍ van Rooij, Eva; Olson, Eric N. 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 872 KB

Hypercholesterolemia in Youth: Opportuni

✍ Catherine J. McNeal; Tala Dajani; Don Wilson; Andrea E. Cassidy-Bushrow; Justin 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 217 KB

Emerging applications of nanomedicine fo

✍ Biana Godin; Jason H. Sakamoto; Rita E. Serda; Alessandro Grattoni; Ali Bouamran 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Global approach to cardiovascular risk i

✍ De Nicola, L; Minutolo, R; Chiodini, P; Zoccali, C; Castellino, P; Donadio, C; S 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB

Perspectives and opportunities for nanom

✍ Lobatto, Mark E.; Fuster, Valentin; Fayad, Zahi A.; Mulder, Willem J. M. 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 51 KB

Changing the research criteria for the d

✍ Berg, Daniela; Lang, Anthony E; Postuma, Ronald B; Maetzler, Walter; Deuschl, Gu 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 178 KB